Axsome Therapeutics Inc

Key Account Mangers x 3, Kanto Area

Japan

Not SpecifiedCompensation
Mid-level (3 to 4 years), Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
Biopharmaceutical, PharmaceuticalIndustries

Key Account Manager

Employment Type: Full time

Position Overview

The Key Account Manager is a field-based position serving as a direct link between PTC Therapeutics and Healthcare Providers (HCPs) and clients within an assigned geographic region. This role is responsible for representing PTC’s products to medical professionals specializing in the diagnostics and treatment of Neurology and Metabolic therapeutic areas. The Key Account Manager manages all operational aspects of pharmaceutical sales and service, including sales generation, communication of clinical and economic benefits, relationship building, educating healthcare staff, and identifying opportunities for commercial and scientific growth. The role requires cross-functional collaboration with internal departments and external resources on sales-related issues and adherence to relevant regulatory requirements and company Standard Operating Procedures (SOPs).

Responsibilities

  • Establishes, develops, and maintains business partnerships with targeted HCPs and staff within the assigned geographical territory.
  • Increases awareness through appropriate scientific information and education (programs) to medical professionals, patients, and families, where appropriate.
  • Develops and executes a region-specific and integrated action plan across all relevant communication mix areas to achieve defined territory and sales goals.
  • Clearly understands and implements the goals of the Account / Marketing Plan and attains sales/patient objectives for assigned products on a monthly, quarterly, and/or yearly basis.
  • Creates consultative, solution-oriented business partnerships with customers by meeting regularly with targeted HCPs and staff to understand and discuss rare diseases and how PTC products can meet their identified needs.
  • Identifies key treatment versus referral centers and facilitates cross-collaboration between centers and their stakeholders to optimize patient care.
  • Drives patient identification initiatives.
  • Establishes, manages, and maintains successful relations with relevant health authorities, key opinion leaders (KOLs), HCPs, and payors.
  • Identifies and resolves product access and reimbursement issues.
  • Provides HCPs and other hospital staff with training and assistance in the indicated disease area and, if applicable, in the use of the product.
  • Communicates according to proper timelines on effects, side effects, and contraindications/risks of drugs and notifies the Pharmacovigilance (PV) Department.
  • Maintains current and comprehensive clinical and pharmacoeconomic knowledge of the product and the treatment area.
  • Collaborates with commercial and scientific colleagues to share best practices and create opportunities to drive the commercial business.
  • Creates account plans and provides feedback for the development of business reviews and ad hoc analysis in relation to the designated area.
  • Performs other tasks and assignments as needed and specified by management.

Requirements

  • Experience working in a small, fast-growing, entrepreneurial orphan/rare disease organization launching innovative therapies is preferred.
  • Bachelor’s degree in a related business or scientific field.

Company Information

PTC Therapeutics is a global commercial biopharmaceutical company. For over 25 years, our team has been deeply committed to a unified purpose: extending life’s moments for children and adults living with a rare disease.

At PTC, we cultivate an inclusive culture where everyone feels valued, respected, and empowered. We welcome candidates from all backgrounds to join our team, fostering a strong sense of belonging.

Learn more about our company and culture: www.ptcbio.com

Skills

Pharmaceutical Sales
Relationship Management
Scientific Information
Medical Education
Business Development
Neurology
Metabolic Disorders

Axsome Therapeutics Inc

Develops therapies for CNS disorders

About Axsome Therapeutics Inc

Axsome Therapeutics develops therapies for central nervous system (CNS) disorders, focusing on conditions like major depressive disorder, treatment-resistant depression, and Alzheimer's agitation. Their main product, AXS-05, is an oral medication that works by blocking NMDA receptors in the brain, which helps regulate mood. This drug has shown positive results in clinical trials and has received special FDA status to speed up its approval process. Unlike many competitors, Axsome emphasizes addressing unmet medical needs in CNS disorders and aims to improve patient outcomes through rigorous research and development. The company's goal is to bring effective treatments to market, enhancing the quality of life for patients suffering from these conditions.

New York City, New YorkHeadquarters
2012Year Founded
$430.7MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
201-500Employees

Benefits

Performance Bonus
Company Equity

Risks

Increased competition from companies like Compass Pathways in the CNS market.
Potential delays in AXS-07 launch amid growing market anticipation.
Departure of key personnel like Lori Englebert may impact strategic direction.

Differentiation

Axsome focuses on CNS disorders with limited current treatment options.
AXS-05, an NMDA receptor antagonist, targets major depressive disorder and treatment-resistant depression.
Axsome's balanced portfolio includes both clinical and research stage products.

Upsides

FDA's fast-tracking of CNS treatments could expedite Axsome's drug approvals.
Increased investment in CNS R&D drives innovation, benefiting Axsome's pipeline.
Growing personalized medicine trend offers Axsome opportunities for tailored therapies.

Land your dream remote job 3x faster with AI